Market capitalization | €752.53m |
Enterprise Value | €751.47m |
P/E (TTM) P/E ratio | 20.84 |
EV/FCF (TTM) EV/FCF | 20.93 |
EV/Sales (TTM) EV/Sales | 3.47 |
P/S ratio (TTM) P/S ratio | 3.47 |
P/B ratio (TTM) P/B ratio | 3.23 |
Dividend yield | 2.51% |
Last dividend (FY24) | €1.25 |
As a Free StocksGuide user, you can view scores for all 6,845 stocks worldwide.
4 Analysts have issued a Equasens forecast:
4 Analysts have issued a Equasens forecast:
Dec '24 |
+/-
%
|
||
Revenue | 217 217 |
1%
1%
|
|
Gross Profit | 149 149 |
1%
1%
|
|
EBITDA | 59 59 |
15%
15%
|
EBIT (Operating Income) EBIT | 44 44 |
21%
21%
|
Net Profit | 36 36 |
23%
23%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Equasens engages in the development of management software packages for drugstores. The company is headquartered in Villers-Les-Nancy, Grand Est. The company went IPO on 2000-10-20. The firm is engaged in publishing and integration of software packages intended for pharmacies, hospitals, health establishments, laboratories, retirement homes and health professionals. Its activity is distributed in publishing and integration of software packages for pharmacies, publishing of IT solutions for health and medico-social establishments and development of solutions and infrastructure for e-Health. The company provides software packages for managing databases, information, stocks, orders, electronic care sheets, etc. The company offers publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, invoicing, tracking collections and accounting, care monitoring, stewardship management, etc. );
Head office | France |
Employees | 1,271 |
Website | equasens.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.